Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Siltuximab> ?p ?o. }
Showing items 1 to 57 of
57
with 100 items per page.
- Siltuximab abstract "Siltuximab (INN) (also known as Sylvant, CNTO 328, Anti-IL-6 chimeric monoclonal antibody or cCLB8) is a chimeric (made from human and mouse proteins) monoclonal antibody. It binds to interleukin-6. Siltuximab has been investigated for the treatment of metastatic renal cell cancer, prostate cancer, and Castleman's disease, among other types of cancer.It has undergone a phase I clinical trial in patients With B-cell non-Hodgkin's lymphoma, multiple myeloma, or Castleman's disease. There were encouraging results in a small trial for advanced ovarian cancer.Encouraging results have been reported from a phase II trial for relapsed or refractory multiple myeloma.On April 23, 2014, Siltuximab was FDA approved under the brand name of Sylvant for the treatment of patients with multicentric Castleman’s disease (MCD) who do not have human immunodeficiency virus (HIV) or human herpesvirus-8 (HHV-8).".
- Siltuximab atcPrefix "none".
- Siltuximab casNumber "541502-14-1".
- Siltuximab fdaUniiCode "T4H8FMA7IM".
- Siltuximab wikiPageID "21198093".
- Siltuximab wikiPageRevisionID "605620825".
- Siltuximab atcPrefix "none".
- Siltuximab c "6450".
- Siltuximab casNumber "541502".
- Siltuximab chemspiderid "NA".
- Siltuximab h "9932".
- Siltuximab hasPhotoCollection Siltuximab.
- Siltuximab legalStatus "Investigational".
- Siltuximab mabType "mab".
- Siltuximab molecularWeight "145".
- Siltuximab n "1688".
- Siltuximab o "2016".
- Siltuximab s "50".
- Siltuximab source "xi/o".
- Siltuximab synonyms "CNTO 328".
- Siltuximab target Interleukin_6.
- Siltuximab type "mab".
- Siltuximab unii "T4H8FMA7IM".
- Siltuximab verifiedfields "changed".
- Siltuximab verifiedrevid "464390611".
- Siltuximab subject Category:Monoclonal_antibodies.
- Siltuximab type Abstraction100002137.
- Siltuximab type Antibody115027189.
- Siltuximab type Chemical114806838.
- Siltuximab type Compound114818238.
- Siltuximab type Macromolecule114944888.
- Siltuximab type Material114580897.
- Siltuximab type Matter100020827.
- Siltuximab type Molecule114682133.
- Siltuximab type MonoclonalAntibodies.
- Siltuximab type MonoclonalAntibody115029781.
- Siltuximab type OrganicCompound114727670.
- Siltuximab type Part113809207.
- Siltuximab type PhysicalEntity100001930.
- Siltuximab type Protein114728724.
- Siltuximab type Relation100031921.
- Siltuximab type Substance100019613.
- Siltuximab type Thing100002452.
- Siltuximab type Unit109465459.
- Siltuximab type Drug.
- Siltuximab type DrugProduct.
- Siltuximab type FunctionalSubstance.
- Siltuximab comment "Siltuximab (INN) (also known as Sylvant, CNTO 328, Anti-IL-6 chimeric monoclonal antibody or cCLB8) is a chimeric (made from human and mouse proteins) monoclonal antibody. It binds to interleukin-6. Siltuximab has been investigated for the treatment of metastatic renal cell cancer, prostate cancer, and Castleman's disease, among other types of cancer.It has undergone a phase I clinical trial in patients With B-cell non-Hodgkin's lymphoma, multiple myeloma, or Castleman's disease.".
- Siltuximab label "Siltuximab".
- Siltuximab label "Siltuximab".
- Siltuximab sameAs Siltuximab.
- Siltuximab sameAs m.05c0nl7.
- Siltuximab sameAs Q3960572.
- Siltuximab sameAs Q3960572.
- Siltuximab sameAs Siltuximab.
- Siltuximab wasDerivedFrom Siltuximab?oldid=605620825.
- Siltuximab isPrimaryTopicOf Siltuximab.